Month: March 2021

If you don’t mind adding an element of mystery to your portfolio, consider Pershing Square Tontine Holdings (NYSE:PSTH). Just be advised that, by acquiring PSTH stock, you’ll own a stake in a special purpose acquisition company (SPAC) with a yet unspecified merger target. Source: Dmitry Demidovich/ShutterStock.com Back in January of this year, I cautioned prospective investors
0 Comments
New Jersey-based Citius Pharmaceuticals (NASDAQ:CTXR) could simply be pigeonholed as a medical product company. But that’s an oversimplification. Prospective CTXR stock investors deserve a much more in-depth discussion of this fascinating company. Source: Iryna Imago / Shutterstock.com Citius describes itself as a “late-stage specialty pharmaceutical company” that develops and commercializes “critical care products, with a particular
0 Comments
A Starlink user terminal being set up. SpaceX Elon Musk’s SpaceX is in talks with the United Kingdom for the company’s Starlink satellite unit to potentially to earn funding as a part of the government’s new $6.9 billion internet infrastructure program, CNBC confirmed. U.K. Minister for Digital Infrastructure Matt Warman recently met with Starlink leadership,
0 Comments
In forex markets, currency trading is conducted frequently among the U.S. dollar, the Japanese yen, the euro, the British pound, and the Canadian dollar. A pip, an acronym for “percentage in point” or “price interest point,” is a tool of measurement related to the smallest price movement made by any exchange rate. Currencies are usually
0 Comments
With Nokia (NYSE:NOK) stock down 39% from its January highs, many investors have started asking if it’s time to buy into the 5G revolution. 5G is clearly one of the biggest cycles of the decade, and Ericsson (NASDAQ:ERIC) can’t single-handedly build out every Western 5G network. At the same time, Chinese telecom behemoth Huawei is
0 Comments
Take a look at some of the biggest movers in the premarket: AstraZeneca (AZN) – The drugmaker said a U.S. study showed its Covid-19 vaccine had 79% efficacy in preventing symptomatic illness, 100% effectiveness against critical disease and hospitalization, and did not pose a higher risk of blood clots. AstraZeneca shares gained 2.2% in premarket
0 Comments
It’s coming any minute now. You’re refreshing the investor relations page constantly, cursing your unbelievably slow WiFi, twitching in anticipation of the latest earnings report. The stock has been slipping for weeks, and the TV pundits are saying the company’s peaked — time to cash out and move on. You know they’re wrong — the analysts, the short-sellers. They’re
0 Comments
It is good news and bad news that those who invest in publicly traded stocks have access to early-stage, unprofitable companies like Romeo Power (NYSE:RMO). RMO stock itself highlights both edges of the proverbial sword. Source: Nick Starichenko/InvestorPlace.com The good news ostensibly is that individual investors can own quality growth stories, even early in their
0 Comments
Gabriela Bhaskar | Bloomberg | Getty Images The $1,400 stimulus checks are hitting Americans’ bank accounts, but Bank of America doesn’t expect the fiscal aid to spur speculative trading in GameStop’s stock. Since the GameStop trading mania that took place in January, the Wall Street firm’s predictive analytics team has been monitoring non-fundamental factors in
0 Comments
A Five Below location. John Greim | LightRocket | Getty Images Check out the companies making headlines after the bell on Wednesday: Five Below – The discount retailer’s shares ticked up 6% after the company’s fourth-quarter results topped Wall Street analyst expectations. Five Below reported earnings per share of $2.20 on revenue of $859 million.
0 Comments
Chartered Market Technician (CMT) is a designation for technical analysts awarded by the CMT Association. Those who earn a CMT demonstrate mastery of investment risk in portfolio management, including quantitative approaches to market research and rules-based trading system design and testing. In the article below, we will review the steps to earning a CMT designation.
0 Comments
Unlock powerful tools and research that will give you an edge in improving the performance of your portfolio. Start your free 30-day Zacks Premium trial! https://www.zacks.com/registration/order.php?add=1691&adid=zp_youtube_introvideo
0 Comments